Population
Patients with hypertension, heart failure, and other comorbidities such as diabetes, obesity, and elderly…
Comparison
Nebivolol vs Conventional β-blockers and other types of…
Design
Review
Authors
Loading...
Nebivolol's NO-mediated effects merit consideration in select hypertension or HF cases; leaves open comparative efficacy versus other agents.
Nebivolol is a third-generation β-blocker that provides vasodilation via the nitric oxide pathway, offering potential benefits in hypertension and heart failure.
Toblli et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: